Table 2.
Research idea | RPS | AEA (%) | |
---|---|---|---|
Answerability | |||
1 | Investigation of the correlation between prognostic scores using the ISARIC 4C Mortality Score* at hospital admission and morbidity at 3 months and 12 months after hospital discharge in patients with and without pre-existing airways disease | 0·864 | 83·8 |
7 | Assessment of whether recovery from severe COVID-19 pneumonia is worse for current smokers with COPD than for non-smokers with COPD | 0·838 | 80·8 |
25 | Investigation of the long-term effects of COVID-19 on the mental health of people with COPD | 0·773 | 75·4 |
Feasibility | |||
1 | Investigation of the correlation between prognostic scores using the ISARIC 4C Mortality Score* at hospital admission and morbidity at 3 months and 12 months after hospital discharge in patients with and without pre-existing airways disease | 0·864 | 83·8 |
15 | Estimation of the incidence of pulmonary embolism up to 1 year after acute COVID-19 | 0·802 | 78·8 |
17 | Examination of whether changes on chest x-ray and CT scans in patients with COVID-19 correlate with subsequent long-term symptoms and outcomes | 0·796 | 76·3 |
Timeliness | |||
1 | Investigation of the correlation between prognostic scores using the ISARIC 4C Mortality Score* at hospital admission and morbidity at 3 months and 12 months after hospital discharge in patients with and without pre-existing airways disease | 0·864 | 83·8 |
15 | Estimation of the incidence of pulmonary embolism up to 1 year after acute COVID-19 | 0·802 | 78·8 |
2 | Assessment of whether 3-month and 6-month post-COVID-19 fatigue, sarcopenia, anxiety, and depression scores are worse in patients with pre-existing airways disease than in those without pre-existing airways disease, and whether any difference is significant when adjusted for severity of in-patient disease | 0·852 | 84·6 |
Burden | |||
21 | Investigation of whether patients at risk of persisting disability after COVID-19 can be identified (eg, with disease indicators at the acute event, frailty scores, or nutritional scores) and targeted for rehabilitation, nutritional interventions, or both | 0·778 | 75·4 |
14 | Assessment of the effects of nutritional status (nutritional depletion or obesity) on recovery from COVID-19 in patients with airways disease and whether this can be modified by nutritional interventions | 0·804 | 77·9 |
5 | Development and validation of tools for remote monitoring of symptoms, and for self-monitoring of symptoms, especially in patients with pre-existing airways disease | 0·841 | 82·1 |
Equity | |||
21 | Investigation of whether patients at risk of persisting disability after COVID-19 can be identified (eg, with disease indicators at the acute event, frailty scores, or nutritional scores) and targeted for rehabilitation, nutritional interventions, or both | 0·778 | 75·4 |
4 | Identification of the predictors of hospital readmission after COVID-19 in patients with pre-existing airways disease compared with those without pre-existing airways disease | 0·847 | 83·3 |
28 | Development of scores to predict long-term respiratory disease severity and risk of mortality in survivors of acute COVID-19 | 0·764 | 73·8 |
Research ideas are numbered by their overall RPS rank.26 AEA=average expert agreement. COPD=chronic obstructive pulmonary disease. ISARIC=International Severe Acute Respiratory and emerging Infections Consortium.34 RPS=research priority score.
A risk stratification score used to predict in-hospital mortality for patients with COVID-19.